Susquehanna International Group’s Acura Pharmaceuticals ACUR Stock Holding History

Susquehanna International Group’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-26,000	Closed	-$20K	–	10805
2016 Q4	$20K	Sell	26,000 -3,300	-11%	-$3.45K	﹤0.01%	9431
2016 Q3	$47K	Sell	29,300 -2,500	-8%	-$4.43K	﹤0.01%	8142
2016 Q2	$59K	Buy	31,800 +15,400	+94%	+$39.7K	﹤0.01%	8207
2016 Q1	$46K	Buy	+16,400	New	+$34.9K	﹤0.01%	8681
2014 Q2	–	Sell	-3,220	Closed	-$24K	–	10344
2014 Q1	$24K	Buy	+3,220	New	+$28K	﹤0.01%	8776

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Susquehanna International Group's ACUR Position: Q3 2015 in Review

Susquehanna International Group sold out of Acura Pharmaceuticals (ACUR) in Q3 2015, closing a stake of 2,052 shares — an estimated $10K sold.

Susquehanna International Group first reported a position in ACUR in Q3 2013 and held it in 6 quarters. The position peaked at $60K in Q3 2013. 22 funds tracked by Wall St. Rank hold ACUR as of Q3 2015.

Susquehanna International Group reported no remaining Acura Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Susquehanna International Group sold 2,052 Acura Pharmaceuticals shares in Q3 2015, an estimated $10K.
Susquehanna International Group first reported a position in Acura Pharmaceuticals in Q3 2013 and held it in 6 quarters.
Susquehanna International Group's Acura Pharmaceuticals position peaked at $60K in Q3 2013.
22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.